Mohammad Haris, Ph.D.

Research Associate Professor, Department of Radiology

Mohammad Haris

 

 
 
 
 
 
Contact Information

Tel:(215) 898-2045
Fax: (215) 573-2113
Email: mharis@upenn.edu

Education

B.Sc. (Chemistry, Zoology, Botany), St. Andrews College, 2000
M.S. (Biochemistry), Dr. Ram Manohar Lohia Avadh University, Ayodhya, 2002
Ph.D. (Biomedical Imaging), Sanjay Gandhi Post Graduate Institute of Medical Sciences, 2007
Postdoctoral Researcher, University of Pennsylvania, 2008-2011
Research Associate, University of Pennsylvania, 2011-2013

Research Interests

  • Molecular Imaging
  • Chemical Exchange Saturation Transfer
  • Magnetic Resonance Imaging
Selected Publications

Google Scholar Link

Lone SN, Bhat AA, Wani NA, Karedath T, Hashem S, Nisar S, Singh M, Bagga P, Das BC, Bedognetti D, Frenneaux MP, Reddy R, El-Rifai W, Haris M, Siddiqi MAmiRNAs as novel immunoregulators in cancer. Semin Cell Dev Biol 26: S1084-9521, April 2021 Notes: doi: 10.1016/j.semcdb.2021.04.013. Online ahead of print.

Nisar S, Yousuf P, Masoodi T, Wani NA, Hashem S, Singh M, Sageena G, Mishra D, Kumar R, Haris M, Bhat AA, Macha MAChemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment. Int J Mol Sci 22(9): 4584, Apr 2021 Notes: doi: 10.3390/ijms22094584.

Bagga P, Rich LJ, Haris M, Wilson N, Schnall MD, Detre JA, Patay Z, Amar G, Akers W, Steinberg J, Krenciute J, Baker S, Reddy RIn vivo monitoring of LDHA expression in glioblastoma using quantitive exchanged-label turnover 1H MRS technique. Neuro-Oncology Advances 3(Suppl 1): i17, March 2021 Notes: Poster Presentation.

Nisar S, Bhat AA, Singh M, Karedath T, Rizwan A, Hashem S, Bagga P, Reddy R, Jamal F, Uddin S, Chand G, Bedognetti D, El-Rifai W, Frenneaux MP, Macha MA, Ahmed I, Haris MInsights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies. Front Cell Dev Biol 5(9): 617281, Feb 2021 Notes: doi: 10.3389/fcell.2021.617281.

Younes N, Syed N, Yadav SK, Haris M, Abdallah Am, Abu-Madi MA Whole-Genome Sequencing Association Study of Low Bone Mineral Density Identifies New Susceptibility Loci in the Phase I Qatar Biobank Cohort. J Pers Med 11(1): 34, January 2021 Notes: doi: 10.3390/jpm11010034.

Bhat AA, Yousuf P, Wani NA, Rizwan A, Chauhan S, Siddiqi M, Bedognetti D, El-Rifai W, Frenneaux MP, Batra S, Haris M, Macha MATumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. Signal Transduct Target Ther 6(1): 12, Jan 2021 Notes: doi: 10.1038/s41392-020-00419-w.

Bhat AA, Nisar S, Maacha S, Carneiro-Lobo T, Akhtar S, Siveen KS, Wani NA, Rizwan A, Bagga P, Singh M, Reddy R, Uddin S, Grivel JC, Chand G, Frenneaux MP, Siddiqi MA, Bedognetti D, El-Rifai W, Macha MA, Haris MCytokine-chemokine network-driven metastasis in esophageal cancer; a promising avenue for targeted therapy. Mol Cancer 20(1): 2, January 2021 Notes: doi: 10.1186/s12943-020-01294-3.

Nisar S, Bhat AA, Hashem S, Yadav SK, Bagga P, Macha MA, Frenneaux MP, Reddy R, Haris M.Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer. J Transl Med 18(1): 471, Dec 2020 Notes: doi: 10.1186/s12967-020-02656-7.

Parker KR, Migliorini D, Perkey E, Yost KE, Bhaduri A, Bagga P, Haris M, Wilson NE, Liu F, Gabunia K, Scholler J, Montine TJ, Bhoj VG, Reddy R, Mohan S, Maillard I, Kriegstein AR, June CH, Chang HY, Posey AD Jr, Satpathy AT.Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies. Cell 183(1): 126-142.e17. September 2020 Notes: doi: 10.1016/j.cell.2020.08.022.

Sher G, Salman NA, Khan AQ, Prabhu KS, Raza A, Kulinski M, Dermime S, Haris M, Junejo K, Uddin S.Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications. Semin Cancer Biol Page: S1044-579X(20)30181-4, August 2020 Notes: DOI:10.1016/j.semcancer.2020.08.009.